Value_Investor
1 week ago
Very Positive Great News today at 4:02 PM just right after the OTC market closing --- see the link below!
https://www.otcmarkets.com/filing/html?id=18534240&guid=Pec-kWqCcmy2B3h
I bet this Long-Expected (from all the shareholders) Exciting Excellent News will trigger a 10-Bagger ~ 30-Bagger Huge Rapid Rally in the coming days/weeks...
We might see the Low Analyst Target $1.400421 before June 18 (Liquidation-Voting Day)! The High Analyst Target will be its most recent high $10.4!
From the latest financial report below of its Same Bio-Tec but DELINQUENT LIMITED-Information-tier OTC peer, it has -$0.56 a share HUGE NEGATIVE Book Value and -$12M HUGE NEGATIVE Net Asset or Shareholder's Equity Value plus 28,301,887 shares HUGE OS but was trading at the Highly-Inflated Ridiculous-High price levels $0.056 ~ $0.259 most recently vs. VINC (NON-DELINQUENT CURRENT-Information-tier) has $0.4 a share HUGE POSITIVE Book Value and -$2.1M HUGE POSITIVE Net Asset or Shareholder's Equity Value plus 5,234,277 shares TINY OS but was trading at the Super-Undervalued Ridiculous-Low price levels $0.0417 ~ $0.1 , LOL!
https://www.otcmarkets.com/filing/html?id=17974768&guid=QH0-keX4vAHwwch
Value_Investor
2 weeks ago
Do you know why this Super Valuable Diamond-In-Rough is trading at such Ridiculous-Low MV --- Mere $0.2M vs. its Shareholder's Equity Value or Net Asset Alone is worthy Ten Times Higher $2.1M and its Total Cash at hand is Shocking-High $4.44M? As a comparison, its almost exactly the Same Winding-Down Bio-Tech but Much-Much-WORSE SEC-DELINQUENCY-Reporting & Limited-Information-tier OTC peer (TTO? has 28,301,887 shares Large OS) was trading at $7,330,189 or $7.33M Shocking-High MV at its most recent high $0.259!
To match the Same MV, VINC will surge to $1.400421 which is 28.6 Times of current Shocking-Low price $0.049!
Note, the MILLIONS dollars worthy HUGE Intangible Assets (such as IP) are not included in the Latest 10-Q financial balance sheet!
So, VINC is Super Undervalued now!
Who are selling their shares at such Dirt Cheap price levels? Why? Are they Very Stupid?
If I had $0.2M cash on hand now, then I would Buy-Out the Entire OS (5,234,277 FIXED TINY shares) at Bottom $0.0417!
Also, VINC is at Hyper Oversold status --- from its most recent high $10.4 to its Bottom $0.0417 within just Four months!
Value_Investor
3 weeks ago
VINC has No any issued preferred shares at all and the common stock is the Only outstanding class with Mere 5,234,277 FIXED Tiny shares! VINC has No any debt at all! Huge Cash position ($4.45M) here! Huge POSITIVE Equity Value ($2.1M) here! So, its Liquidation Value is around $1 a share considering about $3M Huge Intangible Assets Value!
The asks of Level2 are Super Thin like Blue-Sky! Easy to surge to the Upcoming Dollar Land...
Who are still selling Super Cheap shares at such Ridiculous-Low price levels? They just throw the precious money away without thinking of the coming Huge Liquidation Value! At the Bottom this Diamond-In-Rough only has Mere $173,152 Incredible-Low Market Value (MV)! During my decades of OTC stocks investment career, I've never seen a Very Valuable Extra-NASDAQ-Bio-Tech stock's MV could drop to as low as VINC has! For example, its Same Winding-Down OTC peer (28,301,887 shares Large OS) has -$12M Huge NEGATIVE Equity Value but even at its Bottom $0.056 it still has $1,584,906 Huge MV which is Shocking 6.73 Times of VINC's MV at its Bottom $0.0417 while VINC has up to $14.1M Huge POSITIVE Equity Value, LOL!
Some AI application estimates that VINC has $12M Worthy HUGE Intangible Assets which are not included in the Latest 10-Q financial balance sheet!
Buying its peer at its most recent high $0.259 = buying VINC at $1.400421 which is 28.5 Times of current Ridiculous-Low price $0.0492!
Note, $1.400421 = 33.6 Times of its GIANT-Discount Bottom price $0.0417! That means, this Hidden Gem can Easily And Quickly run a 33.6-Bagger Huge Rally Within the coming days...
So, VINC is Super Undervalued now!
VINC is also at Hyper Oversold status --- from its most recent high $10.4 to its Bottom $0.0417 within just Four months!
Value_Investor
1 month ago
TWO Good News Today --- UpToDate 10-Q Financial Report and 10% New Ownerships Report --- see the two links below for the details!
https://www.otcmarkets.com/filing/html?id=18471866&guid=ker-kWt8I-7-B3h
https://www.otcmarkets.com/filing/html?id=18471382&guid=ker-kWt8I-7-B3h
So, the New Total Cash is $4.437M and the Positive Cash Value (CV) is $0.85 a share vs. the Diamond-In-Rough is trading at Incredible-Low price is $0.05 a share now, LOL!
Thus, CV = 17 Times of PPS!
Also, the New Net Asset is $2.066M and the Positive Book Value (BV) is $0.40 a share vs. the Hidden Gem is trading at Ridiculous-Low price is $0.05 a share now, LOL!
Thus, BV = 8 Times of PPS!
Therefore, VINC is Super Undervalued now!
Also, VINC is at Hyper Oversold status --- from $10.4 to $0.045 within just Four Months!
Note, the above-calculated BV and CV have not included the company's Potential HUGE Intangible Assets Value (IAV) which could be up to $12M based on the ChatGPT's estimation! Let's assume that all the IAV worth Only 20% of that estimation value (i.e. $2.4M) now, then the BV will be $0.86 a share and the CV will be $1.31 a share!
So, VINC's Liquidation Value is around the One Dollar ($1.00) a share!
Value_Investor
2 months ago
Who are selling so many Dirt Cheap shares at such Ridiculous-Low price levels? Why? At the Bottom this Diamond-In-Rough only has less than Mere $235,543 Incredible-Low Market Value (MV)! During my decades of OTC stocks investment experience, I've never seen a Very Valuable Extra-NASDAQ-Bio-Tech stock (some AI application estimates $12M worthy Intangible Assets which are not included in the latest financial balance sheet) could crash to as low as VINC! For example, its Same Winding-Down OTC peer (TTO*: 28.3M shares Large OS) has -$12M Huge NEGATIVE Net Asset but at its Bottom $0.056 it still has $1,584,906 Large MV which is Shocking 6.73 Times of the MV of VINC at its Bottom $0.045 while VINC has $15M Huge POSITIVE Net Asset! Why?
At its THREE-Days-Bouncing-High $0.259 that peer has $7,330,189 Huge MV which equals to the MV of VINC at $1.400421!
Note, $1.400421 = 31.1203 Times of its GIANT-Discount Bottom price $0.045! Which means this Hidden Gem can Easily And Quickly soar 31.1203-Bagger Within just a couple of days...
So, VINC is Super Undervalued now!
It is also at Hyper Oversold status --- from $10.4 to $0.045 within just a couple of months!
Value_Investor
2 months ago
How high this Diamond-In-Rought will hit? Based on its Exactly Same-Type of Bio-Tech Winding-Down OTC peer (TOXIC DELINQUENT LIMITED-Information-tier TTO* has 28,301,887 shares Large OS) did most recently --- from its Bottom $0.056 to $0.259, VINC (FULLY-REPORTING CURRENT-Information-tier with Only Mere 5,234,277 shares Tiny OS) will surge to $1.400421 (in the coming days) which is 31.121 Times of its Bottom $0.045 because the MV of its peer at $0.259 = the MV of VINC at $1.400421!
Note, the TOXIC DELINQUENT LIMITED-Information-tier peer has HUGE NEGATIVE Net Asset --- -$11,710,000 HUGE DEBTS vs. this Sought-After FULLY-REPORTING Current-Information-tier VINC has LARGE POSITIVE Net Asset --- +$2,724,000 LARGE Equity Value!
The TOXIC DELINQUENT LIMITED-Information-tier peer has only $2,083,000 LARGE Cash vs. this Sought-After FULLY-REPORTING Current-Information-tier VINC has $4,987,000 HUGE Cash!
Value_Investor
2 months ago
Wow, that CH7-Bankrupt OTC Junk Bio-Tech peer (TTO?) has -$11,710,000 HUGE NEGATIVE Net Asset or Shareholder's Equity Value but it just did hit Shocking-High $7,330,188.733 Huge Market Value just a month ago!
To match the Same Market Value, VINC (5,234,277 shares FIXED TINY OS now) will bounce up to $1.400421 which is 5.1 Times of its current Ridiculous-Low price $0.275!
Note, the most recent high was $10.4 with about the Same financial balance sheet from the second chart below!
Hyper Oversold status --- from nearly $140 (see the first chart below) to Super-Ridiculous-Low 52-week-low $0.22!
Super Undervalued now based on its Huge Cash Value and High Book Value!
Value_Investor
3 months ago
LOL, even a Risky OTC-Market CH7-Bankrupt Garbage (TTOO) could surge to Ridiculous High $0.259 (on 02/21/25) Within just THREE Trading-Sessions from its Highly Inflated Bottom $0.056 (on 02/18/25) with 28,301,887 shares Large OS vs. this Innovative NASDAQ Bio-Tech Hidden Gem (VINC) was trading at as low as $0.486 with only Mere 2,239,580 shares Super Tiny OS!
Based on the Market Value match alone, buying the CH7 Junk at $0.259 = buying VINC at $3.2731 which is 5.95 Times of its current Ridiculous Low price $0.55! Not to mention that this Diamond-In-Rough has $5.43 a share Huge POSITIVE Book Value and $6.323 a share Huge POSITIVE Merger Value (see the link below)! Based on the Minimal $14.16 Millions dollars of Buy-Out deal below and 2,239,580 shares Super TINY OS count, every common share of VINC is worthy $6.323!
https://www.otcmarkets.com/filing/html?id=18164033&guid=o30-knmVG-GTh3h
So, it will be Very Easy for VINC to surge over 01/28/25's Premarket-High $3.35 (which is still far below its Book Value $5.43)!
Note, VINC did bounce up to $3.502 in the After-Hours session on 01/16/25!
Thus, VINC is Super Undervalued now! Easy to run 10-Bagger Quick Huge Rally in the coming days...
Also, VINC is at Hyper Oversold status --- from 12/30/2024's High $10.4 to New Bottom $0.486!
Value_Investor
3 months ago
Great Reverse-Merger News (see the link below) today! The bid is already up to $1.31 so far!
https://finance.yahoo.com/news/vincerx-pharma-announces-non-binding-125200530.html
Based on the $15 Millions dollars of Buy-Out deal above and 2,239,580 shares Super TINY OS count, each common share of VINC is worthy $6.7! So, it might test its most recent high $10.4 again as soon as today...
VINC has $5.43 a share POSITIVE Huge Book Value NASDAQ Bio-Tech v.s. it is trading at as low as $0.75 (i.e. the RATIO of Book Value over the Stock Price was as High as Eye-Popping High 7.24), LOL! Even the company liquidates now its stock's valuation will be worthy Over $4 a share at least!
So, it will be Very Easy to surge over January 28's Premarket-High $3.35 which is still far below its Book Value $5.43!
Note, on January 16, 2025, VINC did bounce up to $3.502 in the After-Hours session!
So, this Hidden Gem (VINC) is Super Undervalued now!
Also, this Diamond-In-Rough (VINC) is at Hyper Oversold status --- from 12/30/2024's High $10.4 to New Bottom $0.75!
Value_Investor
3 months ago
Could anyone explain why a $5.43 a share POSITIVE Huge Book Value NASDAQ Bio-Tech stock was trading at as low as $0.75 (i.e. the RATIO of Book Value over the Stock Price was as High as Eye-Popping High 7.24)? Why is it? Even the company liquidates now its stock's valuation will be worthy Over $4 a share at least!
So, it will be Very Easy to surge over January 28's Premarket-High $3.35 which is still far below its Book Value [color=green]$5.43!
Note, on January 16, 2025, VINC did bounce up to $3.502 in the After-Hours session!
Based on the Minimal $14.16 Millions dollars of Buy-Out deal below and 2,239,580 shares Super TINY OS count, each common share of VINC is worthy $6.323!
https://www.otcmarkets.com/filing/html?id=18164033&guid=o30-knmVG-GTh3h
So, this Hidden Gem (VINC) is Super Undervalued now!
Also, this Diamond-In-Rough (VINC) is at Hyper Oversold status --- from 12/30/2024's High $10.4 to New Bottom $0.75!
Value_Investor
4 months ago
VINC just released a Good News in After-Hours after the market close --- see the link below!
https://ih.advfn.com/stock-market/NASDAQ/vincerx-VINC/stock-news/95460166/form-8-k-current-report
On February 11, 2025, Vincerx Pharma, Inc. (the “Company”) received written notice (the “Compliance Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) informing the Company that it has regained compliance with Nasdaq Listing Rule 5550(a)(2), which requires that companies listed on the Nasdaq Capital Market maintain a minimum bid price of $1.00 per share. Nasdaq notified the Company in the Compliance Notice that, from January 28, 2025 to February 10, 2025, the closing bid price of the Company’s common stock had been $1.00 per share or greater and, accordingly, the Company had regained compliance with Nasdaq Listing Rule 5550(a)(2) and that the matter was now closed.
The POSITIVE Huge Book Value is $5.43 a share vs. the stock is trading at Ridiculous-Low price levels $1.28 now, LOL! Easy to surge over January 28's Premarket-High $3.35 which is still far below its Book Value!
Note, on January 16, 2025, VINC did bounce to $3.502 in the After-Hours session!
Every common share of VINC is worthy $6.323 based on the Minimal $14.16 Millions dollars of Buy-Out deal and 2,239,580 shares Super Tiny OS count!
https://www.otcmarkets.com/filing/html?id=18164033&guid=o30-knmVG-GTh3h
This Diamond-In-Rough is at Hyper Oversold status --- from 12/30/2024's $10.4 to New Bottom $1.18!
So, this Hidden Gem is Super Undervalued now!
Value_Investor
4 months ago
It is Super Hard to understand why this Hidden Gem has $5.4286 per share Huge POSITIVE Book Value but it is trading at such Ridiculous-Low or Huge Discount price levels $1.3x ~ $1.4x?
If I had $3,045,828.80 cash at hand then I'm willing to Buy-Out the Entire OS at current Huge Discount Dirt Cheap price $1.36 because 2,239,580 x $1.36 = $3,045,828.80!
georgie18
4 months ago
VINC...$1.69...🥳
georgie18
Member Level
Re: None
Saturday, February 01, 2025 3:12:37 PM
Post#
31347
of 31358
VINC...$1.58...🥳...https://schrts.co/xpMPMrhfh ...Bullish Deliberation Block Reversal Pattern...on this Oversold Chart... 2million Range Float Post Split...
georgie18
Member Level
Re: georgie18 post# 31
Wednesday, January 29, 2025 8:28:50 AM
Post#
51
of 54
VINC...$2.11 ...Post Split...🥳... Vincerx-Pharma-Inc-and-Oqory-Inc-Highlight-Promising-Data-for-Oqory-s-TROP2-Antibody-Drug-Conjugate-OQY-3258.html" rel="nofollow noopener noreferrer ugc" target="_blank">https://www.globenewswire.com/news-release/2025/01/29/3017128/0/en/Vincerx-Pharma-Inc-and-Oqory-Inc-Highlight-Promising-Data-for-Oqory-s-TROP2-Antibody-Drug-Conjugate-OQY-3258.html
georgie18
Member Level
Re: georgie18 post# 387642
Friday, December 27, 2024 4:35:45 PM
Post#
387643
of 389318
VINC...40s clearing here...🥳
georgie18
Member Level
Re: georgie18 post# 29
Friday, December 27, 2024 4:19:41 PM
Post#
30
of 30
VINC....1946...🥳...Alerted at 2954...PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that it has entered into a binding term sheet for a proposed merger with Oqory, Inc., a privately-held, clinical-stage company developing ADCs for the treatment of multiple oncology indications.
Upon completion of the proposed merger, Oqory, Inc. will merge with Vincerx Pharma, Inc. Post-closing, Oqory equity holders are expected to own approximately 95% of the combined entity, while Vincerx equity holders will hold about 5%. The transaction includes a minimum fully diluted equity value of $13.66 million for existing Vincerx stockholders at closing and, as a condition to the closing of the merger, completion of a concurrent offering of Vincerx equity securities of at least $20 million. Additionally, Oqory-designated investors will provide interim financing to Vincerx of $1.5 million in two tranches, approximately $1,000,000 of which was funded today through the issuance of common stock and pre-funded warrants along with accompanying common stock warrants and approximately $500,000 of which will be funded on or prior to January 31, 2025. The merger is subject to customary closing conditions, including due diligence, regulatory approvals, negotiation of a definitive merger agreement, stockholder approval from both parties, completion of the minimum $20 million financing, and the continued listing of Vincerx's common stock on Nasdaq.
georgie18
Member Level
Re: georgie18 post# 386297
Monday, December 09, 2024 4:01:30 PM
Post#
386750
of 387642
VINC...2194...added here today...🥳
georgie18
Member Level
Re: None
Monday, December 02, 2024 9:42:03 AM
Post#
28
of 28
VINC...2954...🥳...Trying to Reverse here to the Upside...
georgie18
4 months ago
VINC...$1.58...🥳...https://schrts.co/xpMPMrhfh ...Bullish Deliberation Block Reversal Pattern...on this Oversold Chart... 2million Range Float Post Split...
georgie18
Member Level
Re: georgie18 post# 31
Wednesday, January 29, 2025 8:28:50 AM
Post#
51
of 54
VINC...$2.11 ...Post Split...🥳... https://www.globenewswire.com/news-release/2025/01/29/3017128/0/en/Vincerx-Pharma-Inc-and-Oqory-Inc-Highlight-Promising-Data-for-Oqory-s-TROP2-Antibody-Drug-Conjugate-OQY-3258.html
georgie18
Member Level
Re: georgie18 post# 387642
Friday, December 27, 2024 4:35:45 PM
Post#
387643
of 389318
VINC...40s clearing here...🥳
georgie18
Member Level
Re: georgie18 post# 29
Friday, December 27, 2024 4:19:41 PM
Post#
30
of 30
VINC....1946...🥳...Alerted at 2954...PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that it has entered into a binding term sheet for a proposed merger with Oqory, Inc., a privately-held, clinical-stage company developing ADCs for the treatment of multiple oncology indications.
Upon completion of the proposed merger, Oqory, Inc. will merge with Vincerx Pharma, Inc. Post-closing, Oqory equity holders are expected to own approximately 95% of the combined entity, while Vincerx equity holders will hold about 5%. The transaction includes a minimum fully diluted equity value of $13.66 million for existing Vincerx stockholders at closing and, as a condition to the closing of the merger, completion of a concurrent offering of Vincerx equity securities of at least $20 million. Additionally, Oqory-designated investors will provide interim financing to Vincerx of $1.5 million in two tranches, approximately $1,000,000 of which was funded today through the issuance of common stock and pre-funded warrants along with accompanying common stock warrants and approximately $500,000 of which will be funded on or prior to January 31, 2025. The merger is subject to customary closing conditions, including due diligence, regulatory approvals, negotiation of a definitive merger agreement, stockholder approval from both parties, completion of the minimum $20 million financing, and the continued listing of Vincerx's common stock on Nasdaq.
georgie18
Member Level
Re: georgie18 post# 386297
Monday, December 09, 2024 4:01:30 PM
Post#
386750
of 387642
VINC...2194...added here today...🥳
georgie18
Member Level
Re: None
Monday, December 02, 2024 9:42:03 AM
Post#
28
of 28
VINC...2954...🥳...Trying to Reverse here to the Upside...
georgie18
5 months ago
VINC...$2.11 ...Post Split...🥳... https://www.globenewswire.com/news-release/2025/01/29/3017128/0/en/Vincerx-Pharma-Inc-and-Oqory-Inc-Highlight-Promising-Data-for-Oqory-s-TROP2-Antibody-Drug-Conjugate-OQY-3258.html
georgie18
Member Level
Re: georgie18 post# 387642
Friday, December 27, 2024 4:35:45 PM
Post#
387643
of 389318
VINC...40s clearing here...🥳
georgie18
Member Level
Re: georgie18 post# 29
Friday, December 27, 2024 4:19:41 PM
Post#
30
of 30
VINC....1946...🥳...Alerted at 2954...PALO ALTO, Calif., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that it has entered into a binding term sheet for a proposed merger with Oqory, Inc., a privately-held, clinical-stage company developing ADCs for the treatment of multiple oncology indications.
Upon completion of the proposed merger, Oqory, Inc. will merge with Vincerx Pharma, Inc. Post-closing, Oqory equity holders are expected to own approximately 95% of the combined entity, while Vincerx equity holders will hold about 5%. The transaction includes a minimum fully diluted equity value of $13.66 million for existing Vincerx stockholders at closing and, as a condition to the closing of the merger, completion of a concurrent offering of Vincerx equity securities of at least $20 million. Additionally, Oqory-designated investors will provide interim financing to Vincerx of $1.5 million in two tranches, approximately $1,000,000 of which was funded today through the issuance of common stock and pre-funded warrants along with accompanying common stock warrants and approximately $500,000 of which will be funded on or prior to January 31, 2025. The merger is subject to customary closing conditions, including due diligence, regulatory approvals, negotiation of a definitive merger agreement, stockholder approval from both parties, completion of the minimum $20 million financing, and the continued listing of Vincerx's common stock on Nasdaq.
georgie18
Member Level
Re: georgie18 post# 386297
Monday, December 09, 2024 4:01:30 PM
Post#
386750
of 387642
VINC...2194...added here today...🥳
georgie18
Member Level
Re: None
Monday, December 02, 2024 9:42:03 AM
Post#
28
of 28
VINC...2954...🥳...Trying to Reverse here to the Upside...